EDIT

Editas Medicine, Inc.

CIK 0001650664 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)

$3.30

↓ 0.37 (-10.08%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap

$323.09M

P/E Ratio

-2.97

EPS

-1.80

Dividend Yield

Not covered

52W Position

57%

Beta

2.23

Valuation multiples

Fwd P/E

Not covered

PEG

0.00

P/B

73.30

P/S

8.35

EV/Revenue

6.57

ROE

-2471.7%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 57%

$1.66$4.54

Latest Financials

2025-12-31 FY

Revenue

$40.52M

Net Income

-$160.06M

Total Assets

$186.53M

Free Cash Flow

-$165.85M

EDIT

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

EDIT

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news